Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.08 trillion and total revenue of $110 billion.
Market Cap
1.08T
Revenue
110B
Profits
-41.42B
PE Ratio
n/a
Profit Margin
-37.66%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.59B | -2.26% | 1,102,822 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 61.21B | -2.36% | 815,446 | 14.92B |
| 3 | ARGX | argenx SE | 54.82B | -2.47% | 349,271 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.88B | -2.17% | 927,325 | 4.29B |
| 5 | RPRX | Royalty Pharma plc | 31.39B | -2.00% | 2,228,933 | 2.44B |
| 6 | RVMD | Revolution Medicines, Inc. | 30.65B | -3.58% | 3,282,937 | - |
| 7 | ONC | BeOne Medicines AG | 29.31B | -1.70% | 291,079 | 5.70B |
| 8 | BNTX | BioNTech SE | 21.79B | -0.40% | 1,213,803 | 3.23B |
| 9 | INCY | Incyte Corporation | 21.06B | 2.09% | 2,654,378 | 5.36B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.43B | -2.20% | 4,267,678 | 8.26M |
| 11 | INSM | Insmed Incorporated | 19.92B | -7.23% | 5,425,119 | 819.56M |
| 12 | MRNA | Moderna, Inc. | 18.25B | -3.65% | 4,217,037 | 2.23B |
| 13 | GMAB | Genmab A/S | 15.26B | -2.55% | 876,185 | 3.90B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 14.41B | 0.19% | 954,759 | 4.44B |
| 15 | EXEL | Exelixis, Inc. | 13.22B | -0.77% | 3,104,615 | 2.38B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.20B | -0.41% | 2,128,413 | 579.96M |
| 17 | ASND | Ascendis Pharma A/S | 13.03B | -1.61% | 387,643 | 998.25M |
| 18 | AXSM | Axsome Therapeutics, Inc. | 12.68B | 0.28% | 741,193 | 708.24M |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.13B | -1.61% | 1,595,747 | 1.06B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.87B | -1.17% | 287,530 | 1.13B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.86B | -3.00% | 2,055,805 | 3.24B |
| 22 | SMMT | Summit Therapeutics Inc. | 10.13B | -8.68% | 8,627,914 | - |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.96B | -3.55% | 1,546,381 | 622.01M |
| 24 | NUVL | Nuvalent, Inc. | 9.74B | 0.08% | 6,272,833 | - |
| 25 | KRYS | Krystal Biotech, Inc. | 9.21B | 0.86% | 301,892 | 417.30M |
| 26 | CYTK | Cytokinetics, Incorporated | 9.11B | -2.02% | 1,404,867 | 105.82M |
| 27 | CORT | Corcept Therapeutics Incorporated | 8.39B | 0.81% | 1,494,264 | 769.10M |
| 28 | HALO | Halozyme Therapeutics, Inc. | 8.36B | -1.37% | 1,946,813 | 1.51B |
| 29 | TECH | Bio-Techne Corporation | 8.22B | -3.51% | 2,646,072 | 1.21B |
| 30 | ABVX | ABIVAX Société Anonyme | 7.74B | -4.57% | 1,363,685 | 5.67M |
| 31 | IBRX | ImmunityBio, Inc. | 7.31B | -3.72% | 9,421,149 | 140.98M |
| 32 | PTGX | Protagonist Therapeutics, Inc. | 6.80B | -0.09% | 770,170 | 74.06M |
| 33 | PRAX | Praxis Precision Medicines, Inc. | 6.71B | -3.86% | 407,983 | 7.46M |
| 34 | TGTX | TG Therapeutics, Inc. | 6.61B | 7.49% | 5,112,656 | 700.35M |
| 35 | PCVX | Vaxcyte, Inc. | 6.56B | -3.11% | 1,079,601 | - |
| 36 | SYRE | Spyre Therapeutics, Inc. | 6.52B | -1.78% | 981,376 | - |
| 37 | LEGN | Legend Biotech Corporation | 6.47B | 4.09% | 1,909,994 | 1.14B |
| 38 | KYMR | Kymera Therapeutics, Inc. | 6.44B | 1.72% | 604,682 | 51.48M |
| 39 | IMVT | Immunovant, Inc. | 6.40B | -1.36% | 1,493,587 | - |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.20B | -2.68% | 789,054 | - |
| 41 | CNTA | Centessa Pharmaceuticals plc | 6.14B | -0.18% | 1,780,789 | 15.00M |
| 42 | PTCT | PTC Therapeutics, Inc. | 6.09B | -0.33% | 1,190,858 | 827.11M |
| 43 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.87B | -2.45% | 851,948 | 217.17M |
| 44 | MIRM | Mirum Pharmaceuticals, Inc. | 5.73B | -1.55% | 471,800 | 569.61M |
| 45 | BLTE | Belite Bio, Inc | 5.37B | -3.39% | 96,882 | - |
| 46 | COGT | Cogent Biosciences, Inc. | 5.36B | -1.88% | 2,510,057 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 5.28B | -3.27% | 1,457,699 | - |
| 48 | LGND | Ligand Pharmaceuticals Incorporated | 4.97B | 2.04% | 240,272 | 274.48M |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 4.96B | -2.75% | 1,259,397 | 7.50M |
| 50 | CAI | Caris Life Sciences, Inc. | 4.85B | 1.18% | 2,606,038 | 907.29M |
| 51 | CGON | CG Oncology, Inc. | 4.84B | -3.09% | 800,660 | 5.07M |
| 52 | CRSP | CRISPR Therapeutics AG | 4.77B | -3.96% | 1,409,161 | 4.10M |
| 53 | TVTX | Travere Therapeutics, Inc. | 4.35B | -3.77% | 1,631,601 | 536.20M |
| 54 | CELC | Celcuity Inc. | 4.30B | -4.70% | 1,965,712 | - |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.18B | -9.64% | 4,705,609 | 1.34M |
| 56 | ERAS | Erasca, Inc. | 4.16B | -0.30% | 3,655,657 | - |
| 57 | TNGX | Tango Therapeutics, Inc. | 4.15B | -9.13% | 9,849,850 | 56.99M |
| 58 | MANE | Veradermics, Incorporated | 3.88B | -3.05% | 399,525 | - |
| 59 | ORKA | Oruka Therapeutics, Inc. | 3.86B | -4.33% | 1,017,135 | - |
| 60 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | - | 960,202 | 596.96M |
| 61 | PBLS | Parabilis Medicines, Inc. | 3.76B | 58.00% | 5,496,700 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.64B | -2.70% | 1,231,797 | 1.10B |
| 63 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.62B | -1.86% | 625,286 | 18.07M |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.54B | -3.35% | 1,345,437 | - |
| 65 | NAMS | NewAmsterdam Pharma Company N.V. | 3.43B | -3.49% | 861,002 | 22.57M |
| 66 | DNLI | Denali Therapeutics Inc. | 3.27B | -0.87% | 2,484,047 | - |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.22B | 0.32% | 95,397 | 803.79M |
| 68 | VKTX | Viking Therapeutics, Inc. | 3.22B | -5.06% | 2,739,117 | - |
| 69 | GPCR | Structure Therapeutics Inc. | 2.95B | 0.68% | 1,158,764 | - |
| 70 | RLAY | Relay Therapeutics, Inc. | 2.94B | -4.26% | 2,520,612 | 10.68M |
| 71 | BEAM | Beam Therapeutics Inc. | 2.94B | -3.22% | 1,528,869 | 164.01M |
| 72 | DYN | Dyne Therapeutics, Inc. | 2.92B | -1.09% | 1,267,565 | - |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 2.91B | 1.93% | 1,412,373 | 415.62M |
| 74 | RCUS | Arcus Biosciences, Inc. | 2.78B | -6.43% | 2,249,758 | 236.00M |
| 75 | TARS | Tarsus Pharmaceuticals, Inc. | 2.64B | -0.45% | 319,938 | 535.08M |
| 76 | IRON | Disc Medicine, Inc. | 2.57B | -1.59% | 271,614 | - |
| 77 | ALMS | Alumis Inc. | 2.56B | 0.25% | 1,184,348 | 8.40M |
| 78 | DFTX | Definium Therapeutics, Inc. | 2.53B | 1.26% | 2,538,886 | - |
| 79 | KLRA | Kailera Therapeutics, Inc. | 2.48B | -3.00% | 368,596 | - |
| 80 | IDYA | IDEAYA Biosciences, Inc. | 2.42B | -1.67% | 1,559,394 | 225.27M |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.30B | -0.84% | 490,422 | 865.00K |
| 82 | VERA | Vera Therapeutics, Inc. | 2.27B | -0.60% | 697,197 | - |
| 83 | RARE | Ultragenyx Pharmaceutical Inc. | 2.26B | 0.79% | 1,200,756 | 670.00M |
| 84 | ELVN | Enliven Therapeutics, Inc. | 2.25B | 2.46% | 1,293,455 | - |
| 85 | PHVS | Pharvaris N.V. | 2.20B | -0.28% | 183,661 | - |
| 86 | IMNM | Immunome, Inc. | 2.06B | -1.25% | 1,140,767 | 4.02M |
| 87 | HRMY | Harmony Biosciences Holdings, Inc. | 2.05B | 4.05% | 1,862,006 | 899.11M |
| 88 | AUPH | Aurinia Pharmaceuticals Inc. | 2.01B | -0.76% | 1,018,623 | 298.30M |
| 89 | ADMA | ADMA Biologics, Inc. | 1.97B | 4.43% | 4,177,085 | 509.86M |
| 90 | KOD | Kodiak Sciences Inc. | 1.96B | 1.13% | 677,481 | - |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 1.96B | -1.74% | 1,048,791 | - |
| 92 | ZLAB | Zai Lab Limited | 1.94B | 3.66% | 1,171,343 | 453.28M |
| 93 | NKTR | Nektar Therapeutics | 1.92B | 0.98% | 874,079 | 55.63M |
| 94 | OCUL | Ocular Therapeutix, Inc. | 1.91B | 3.19% | 2,666,630 | 52.04M |
| 95 | VCEL | Vericel Corporation | 1.91B | 1.08% | 617,750 | 292.09M |
| 96 | TRVI | Trevi Therapeutics, Inc. | 1.90B | -1.40% | 931,636 | - |
| 97 | LKFT | Lakefront Biotherapeutics NV | 1.87B | 1.17% | 291,518 | 1.20B |
| 98 | MESO | Mesoblast Limited | 1.83B | -3.36% | 99,339 | 65.38M |
| 99 | STOK | Stoke Therapeutics, Inc. | 1.77B | -3.03% | 534,024 | 32.08M |
| 100 | VRDN | Viridian Therapeutics, Inc. | 1.74B | -3.31% | 1,417,793 | 70.92M |
| 101 | AGIO | Agios Pharmaceuticals, Inc. | 1.72B | 2.63% | 1,020,351 | 66.05M |
| 102 | NTLA | Intellia Therapeutics, Inc. | 1.70B | -5.35% | 3,961,341 | 66.09M |
| 103 | INVA | Innoviva, Inc. | 1.70B | 2.04% | 727,520 | 420.69M |
| 104 | QURE | uniQure N.V. | 1.69B | 1.36% | 1,120,007 | 18.09M |
| 105 | IOVA | Iovance Biotherapeutics, Inc. | 1.69B | -2.58% | 8,880,518 | 285.61M |
| 106 | GENB | Generate Biomedicines, Inc. | 1.69B | -0.23% | 382,465 | 30.30M |
| 107 | RAPP | Rapport Therapeutics, Inc. | 1.68B | -1.80% | 344,562 | 20.00M |
| 108 | ZYME | Zymeworks Inc. | 1.67B | -1.72% | 620,733 | 81.26M |
| 109 | BHVN | Biohaven Ltd. | 1.67B | -0.18% | 3,935,883 | - |
| 110 | NBTX | Nanobiotix S.A. | 1.66B | -2.30% | 77,408 | 38.27M |
| 111 | RXRX | Recursion Pharmaceuticals, Inc. | 1.61B | -5.59% | 19,534,292 | 66.41M |
| 112 | AAPG | Ascentage Pharma Group International | 1.61B | 1.58% | 1,616 | 82.08M |
| 113 | SRPT | Sarepta Therapeutics, Inc. | 1.60B | -4.91% | 2,332,168 | 2.18B |
| 114 | NUVB | Nuvation Bio Inc. | 1.59B | -7.10% | 6,614,528 | 143.05M |
| 115 | NRIX | Nurix Therapeutics, Inc. | 1.58B | -2.17% | 2,539,748 | 71.78M |
| 116 | SNDX | Syndax Pharmaceuticals, Inc. | 1.56B | -0.62% | 1,395,263 | 217.17M |
| 117 | ABCL | AbCellera Biologics Inc. | 1.55B | -3.96% | 3,750,820 | 79.21M |
| 118 | TSHA | Taysha Gene Therapies, Inc. | 1.55B | 0.75% | 2,180,736 | 7.47M |
| 119 | FTRE | Fortrea Holdings Inc. | 1.55B | -3.20% | 1,051,928 | 2.71B |
| 120 | SION | Sionna Therapeutics, Inc. | 1.54B | 1.01% | 316,937 | - |
| 121 | ANAB | AnaptysBio, Inc. | 1.52B | 0.91% | 445,357 | 232.39M |
| 122 | TYRA | Tyra Biosciences, Inc. | 1.51B | -2.00% | 628,730 | - |
| 123 | MBX | MBX Biosciences, Inc. | 1.48B | 3.75% | 971,306 | - |
| 124 | CAPR | Capricor Therapeutics, Inc. | 1.47B | -2.61% | 1,484,394 | 11.13M |
| 125 | PVLA | Palvella Therapeutics, Inc. | 1.46B | -2.19% | 359,267 | - |
| 126 | KALV | KalVista Pharmaceuticals, Inc. | 1.44B | 0.04% | 4,272,770 | 114.48M |
| 127 | AVBP | ArriVent BioPharma, Inc. | 1.42B | -0.08% | 373,847 | - |
| 128 | IMCR | Immunocore Holdings plc | 1.42B | -2.17% | 318,095 | 412.81M |
| 129 | NVAX | Novavax, Inc. | 1.41B | -1.27% | 3,098,778 | 596.34M |
| 130 | GHRS | GH Research PLC | 1.40B | 0.05% | 140,664 | - |
| 131 | GLUE | Monte Rosa Therapeutics, Inc. | 1.40B | -0.54% | 873,050 | 42.95M |
| 132 | ATAI | AtaiBeckley Inc. | 1.39B | -2.83% | 3,280,897 | 3.49M |
| 133 | VIR | Vir Biotechnology, Inc. | 1.39B | -3.06% | 1,707,654 | 65.50M |
| 134 | PGEN | Precigen, Inc. | 1.39B | 4.85% | 4,243,659 | 31.60M |
| 135 | ARDX | Ardelyx, Inc. | 1.39B | 0.18% | 2,939,943 | 427.68M |
| 136 | SEPN | Septerna, Inc. | 1.37B | -1.74% | 171,877 | 72.26M |
| 137 | URGN | UroGen Pharma Ltd. | 1.36B | -0.64% | 618,848 | 140.49M |
| 138 | SLS | SELLAS Life Sciences Group, Inc. | 1.33B | -6.90% | 6,680,875 | - |
| 139 | BCAX | Bicara Therapeutics Inc. | 1.33B | -1.61% | 667,012 | - |
| 140 | INBX | Inhibrx Biosciences, Inc. | 1.31B | 0.42% | 398,986 | 1.30M |
| 141 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.31B | -0.39% | 2,704,674 | 204.73M |
| 142 | MAZE | Maze Therapeutics, Inc. | 1.31B | -1.13% | 746,808 | 20.00M |
| 143 | SVRA | Savara Inc. | 1.29B | 3.25% | 1,962,249 | - |
| 144 | MLTX | MoonLake Immunotherapeutics | 1.29B | -1.74% | 694,595 | - |
| 145 | MPLT | MapLight Therapeutics, Inc. | 1.26B | -5.02% | 184,014 | - |
| 146 | DMRA | Damora Therapeutics, Inc. | 1.24B | -3.84% | 531,780 | - |
| 147 | IMTX | Immatics N.V. | 1.21B | -3.17% | 360,831 | 43.00M |
| 148 | AVLN | Avalyn Pharma Inc. | 1.19B | -0.49% | 342,826 | - |
| 149 | ZBIO | Zenas BioPharma, Inc. | 1.13B | -2.82% | 432,797 | 10.00M |
| 150 | COAG | Hemab Therapeutics Holdings, Inc. | 1.13B | -5.17% | 230,969 | - |
| 151 | MNKD | MannKind Corporation | 1.12B | 1.68% | 4,478,122 | 360.78M |
| 152 | WVE | Wave Life Sciences Ltd. | 1.09B | -2.08% | 2,907,137 | 71.80M |
| 153 | EYPT | EyePoint, Inc. | 1.03B | 4.76% | 1,161,516 | 7.61M |
| 154 | AKTS | Aktis Oncology, Inc. | 1.03B | -2.11% | 123,965 | 8.28M |
| 155 | ABSI | Absci Corporation | 994.67M | -6.59% | 5,512,890 | 1.84M |
| 156 | DBVT | DBV Technologies S.A. | 942.28M | 0.12% | 297,777 | 5.74M |
| 157 | CRVS | Corvus Pharmaceuticals, Inc. | 938.45M | -0.09% | 1,506,904 | - |
| 158 | SPRY | ARS Pharmaceuticals, Inc. | 918.06M | -1.75% | 1,481,326 | 98.99M |
| 159 | SPTX | Seaport Therapeutics, Inc. | 907.84M | -3.06% | 156,156 | - |
| 160 | JBIO | Jade Biosciences, Inc. | 905.83M | 0.26% | 1,375,102 | - |
| 161 | PHAR | Pharming Group N.V. | 882.51M | -2.46% | 3,864 | 369.49M |
| 162 | XNCR | Xencor, Inc. | 877.10M | -0.50% | 650,972 | 97.36M |
| 163 | OLMA | Olema Pharmaceuticals, Inc. | 857.75M | -6.03% | 1,788,980 | - |
| 164 | MGTX | MeiraGTx Holdings plc | 846.45M | -0.76% | 437,882 | 79.76M |
| 165 | TBPH | Theravance Biopharma, Inc. | 843.92M | -0.73% | 341,151 | 109.78M |
| 166 | LXRX | Lexicon Pharmaceuticals, Inc. | 835.09M | - | 1,283,064 | 69.64M |
| 167 | DRTS | Alpha Tau Medical Ltd. | 833.23M | 0.54% | 409,057 | - |
| 168 | LBRX | LB Pharmaceuticals Inc | 814.13M | -3.01% | 193,576 | - |
| 169 | ABUS | Arbutus Biopharma Corporation | 813.86M | -3.06% | 1,965,971 | 191.45M |
| 170 | JANX | Janux Therapeutics, Inc. | 801.94M | -3.45% | 932,177 | 13.73M |
| 171 | ZVRA | Zevra Therapeutics, Inc. | 798.05M | -1.17% | 2,719,218 | 122.29M |
| 172 | SANA | Sana Biotechnology, Inc. | 784.78M | - | 2,679,772 | - |
| 173 | ORIC | ORIC Pharmaceuticals, Inc. | 780.52M | -5.75% | 2,085,165 | - |
| 174 | PHAT | Phathom Pharmaceuticals, Inc. | 780.00M | - | 827,372 | 204.89M |
| 175 | IVA | Inventiva S.A. | 779.95M | -4.79% | 645,052 | 7.94M |
| 176 | ANNX | Annexon, Inc. | 773.34M | -9.23% | 2,627,034 | - |
| 177 | KURA | Kura Oncology, Inc. | 770.56M | -1.48% | 1,816,006 | 71.64M |
| 178 | ODTX | Odyssey Therapeutics, Inc. | 764.22M | -5.21% | 421,950 | 2.98M |
| 179 | CGEM | Cullinan Therapeutics, Inc. | 740.57M | -8.57% | 2,102,370 | - |
| 180 | OMER | Omeros Corporation | 738.23M | 2.31% | 1,375,356 | 9.89M |
| 181 | EVMN | Evommune, Inc. | 738.02M | - | 562,959 | 10.00M |
| 182 | GERN | Geron Corporation | 705.67M | -1.79% | 14,737,110 | 196.12M |
| 183 | VOR | Vor Biopharma Inc. | 704.42M | -2.11% | 771,497 | - |
| 184 | REPL | Replimune Group, Inc. | 699.39M | -8.33% | 3,373,376 | - |
| 185 | ANRO | Alto Neuroscience, Inc. | 690.65M | -6.95% | 347,091 | - |
| 186 | AVTX | Avalo Therapeutics, Inc. | 688.61M | 1.55% | 1,635,174 | 59.00K |
| 187 | CRMD | CorMedix Inc. | 688.02M | 1.39% | 1,317,079 | 400.05M |
| 188 | AURA | Aura Biosciences, Inc. | 675.03M | -3.62% | 676,686 | - |
| 189 | RLMD | Relmada Therapeutics, Inc. | 669.20M | 1.75% | 1,456,811 | - |
| 190 | DSGN | Design Therapeutics, Inc. | 665.79M | 1.04% | 614,656 | - |
| 191 | OCS | Oculis Holding AG | 662.46M | -0.09% | 644,688 | 1.40M |
| 192 | SLDB | Solid Biosciences Inc. | 650.75M | 0.61% | 1,137,314 | - |
| 193 | CTMX | CytomX Therapeutics, Inc. | 633.52M | -2.35% | 2,016,823 | 35.54M |
| 194 | TENX | Tenax Therapeutics, Inc. | 621.17M | -1.68% | 381,299 | - |
| 195 | DRUG | Bright Minds Biosciences Inc. | 614.69M | -9.35% | 708,274 | - |
| 196 | ALLO | Allogene Therapeutics, Inc. | 614.38M | -2.20% | 7,941,583 | 22.00K |
| 197 | CADL | Candel Therapeutics, Inc. | 611.81M | -3.69% | 1,600,377 | - |
| 198 | SGP | SpyGlass Pharma, Inc. | 600.68M | -0.71% | 84,426 | - |
| 199 | ACHV | Achieve Life Sciences, Inc. | 590.29M | 2.68% | 1,266,385 | - |
| 200 | CBIO | Crescent Biopharma, Inc. | 583.83M | -2.39% | 169,080 | 11.88M |
| 201 | TRAX | First Tracks Biotherapeutics, Inc. | 572.93M | 2.82% | 365,430 | - |
| 202 | ACRS | Aclaris Therapeutics, Inc. | 572.62M | -4.65% | 1,224,418 | 8.37M |
| 203 | RIGL | Rigel Pharmaceuticals, Inc. | 571.90M | 0.62% | 209,962 | 299.77M |
| 204 | IMMX | Immix Biopharma, Inc. | 570.89M | 2.12% | 1,109,239 | - |
| 205 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 570.36M | -1.93% | 308,059 | - |
| 206 | GYRE | Gyre Therapeutics, Inc. | 543.66M | -2.77% | 71,007 | 117.05M |
| 207 | MDXG | MiMedx Group, Inc. | 542.16M | -1.89% | 967,996 | 389.42M |
| 208 | TECX | Tectonic Therapeutic, Inc. | 529.28M | -1.33% | 101,741 | - |
| 209 | XOMA | XOMA Royalty Corporation | 524.03M | -0.39% | 125,243 | 48.56M |
| 210 | DNA | Ginkgo Bioworks Holdings, Inc. | 518.68M | -3.76% | 1,004,656 | 151.40M |
| 211 | CLYM | Climb Bio, Inc. | 515.90M | -3.05% | 587,741 | - |
| 212 | AGMB | AgomAb Therapeutics NV | 513.66M | 6.43% | 97,030 | - |
| 213 | ALT | Altimmune, Inc. | 507.58M | -1.88% | 3,042,390 | 36.00K |
| 214 | PROK | ProKidney Corp. | 504.44M | - | 671,527 | 889.00K |
| 215 | CABA | Cabaletta Bio, Inc. | 495.69M | -5.59% | 2,897,097 | - |
| 216 | VALN | Valneva SE | 492.14M | -0.94% | 16,121 | 180.25M |
| 217 | PRME | Prime Medicine, Inc. | 489.47M | -5.90% | 2,551,084 | 4.03M |
| 218 | KYTX | Kyverna Therapeutics, Inc. | 463.66M | -2.42% | 527,553 | - |
| 219 | FDMT | 4D Molecular Therapeutics, Inc. | 455.85M | -5.53% | 623,640 | 88.24M |
| 220 | EIKN | Eikon Therapeutics, Inc. | 452.60M | -4.68% | 155,059 | - |
| 221 | ARVN | Arvinas, Inc. | 450.36M | -3.19% | 680,255 | 89.40M |
| 222 | NGNE | Neurogene Inc. | 442.61M | -2.78% | 237,443 | 925.00K |
| 223 | ASMB | Assembly Biosciences, Inc. | 441.13M | -2.02% | 195,486 | 71.10M |
| 224 | STRO | Sutro Biopharma, Inc. | 432.32M | 1.16% | 196,992 | 99.61M |
| 225 | CCCC | C4 Therapeutics, Inc. | 427.90M | 8.10% | 2,276,908 | 34.86M |
| 226 | OVID | Ovid Therapeutics Inc. | 425.54M | -5.79% | 1,607,425 | 7.12M |
| 227 | CTNM | Contineum Therapeutics, Inc. | 422.47M | -1.14% | 136,357 | - |
| 228 | ANL | Adlai Nortye Ltd. | 418.80M | -3.41% | 69,773 | 5.00M |
| 229 | PRTA | Prothena Corporation plc | 414.11M | -6.61% | 456,436 | 57.94M |
| 230 | FBRX | Forte Biosciences, Inc. | 411.01M | -1.06% | 254,561 | - |
| 231 | OCGN | Ocugen, Inc. | 402.84M | -4.03% | 5,758,335 | 4.47M |
| 232 | SGMT | Sagimet Biosciences Inc. | 401.39M | -0.31% | 718,807 | - |
| 233 | MNPR | Monopar Therapeutics Inc. | 398.04M | -1.48% | 81,012 | - |
| 234 | RZLT | Rezolute, Inc. | 398.02M | -2.31% | 1,229,198 | - |
| 235 | AUTL | Autolus Therapeutics plc | 393.89M | 1.37% | 890,705 | 92.62M |
| 236 | PRLD | Prelude Therapeutics Incorporated | 391.75M | 0.63% | 192,717 | 16.72M |
| 237 | EPRX | Eupraxia Pharmaceuticals Inc. | 387.87M | -0.67% | 219,040 | - |
| 238 | IPSC | Century Therapeutics, Inc. | 382.35M | -4.07% | 722,283 | 109.16M |
| 239 | EDIT | Editas Medicine, Inc. | 380.59M | -6.42% | 1,485,298 | 38.69M |
| 240 | VTVT | vTv Therapeutics Inc. | 377.75M | -3.49% | 17,414 | 36.84M |
| 241 | VNDA | Vanda Pharmaceuticals Inc. | 362.62M | -1.47% | 855,904 | 217.78M |
| 242 | ARTV | Artiva Biotherapeutics, Inc. | 360.52M | 2.06% | 491,214 | 251.00K |
| 243 | LRMR | Larimar Therapeutics, Inc. | 359.08M | -1.71% | 3,228,006 | - |
| 244 | PBYI | Puma Biotechnology, Inc. | 357.31M | -0.14% | 163,270 | 227.18M |
| 245 | BNTC | Benitec Biopharma Inc. | 356.94M | -3.89% | 71,338 | - |
| 246 | XFOR | X4 Pharmaceuticals, Inc. | 351.81M | -3.12% | 399,640 | 9.01M |
| 247 | AVIR | Atea Pharmaceuticals, Inc. | 351.32M | 0.57% | 237,443 | - |
| 248 | CMPX | Compass Therapeutics, Inc. | 345.77M | -6.80% | 3,521,737 | 850.00K |
| 249 | OABI | OmniAb, Inc. | 345.03M | -0.83% | 399,293 | 28.94M |
| 250 | UPB | Upstream Bio, Inc. | 341.76M | -6.13% | 448,311 | 3.32M |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 341.67M | 3.52% | 142,985 | 69.21M |
| 252 | ZURA | Zura Bio Limited | 336.83M | -3.79% | 644,933 | - |
| 253 | VSTM | Verastem, Inc. | 330.40M | -1.57% | 2,220,993 | 49.59M |
| 254 | CNXU | Conexeu Sciences Inc. | 329.02M | -6.60% | 56,771 | - |
| 255 | GLSI | Greenwich LifeSciences, Inc. | 324.54M | -0.54% | 64,550 | - |
| 256 | LXEO | Lexeo Therapeutics, Inc. | 324.29M | -2.59% | 487,745 | - |
| 257 | RGNX | REGENXBIO Inc. | 316.91M | -3.31% | 821,619 | 87.82M |
| 258 | STTK | Shattuck Labs, Inc. | 316.69M | -3.28% | 2,174,700 | 1.00M |
| 259 | IRD | Opus Genetics, Inc. | 316.63M | -4.66% | 819,056 | 11.98M |
| 260 | LCTX | Lineage Cell Therapeutics, Inc. | 306.64M | 0.82% | 1,230,610 | 14.78M |
| 261 | LYEL | Lyell Immunopharma, Inc. | 306.26M | 3.35% | 146,362 | 31.00K |
| 262 | ABEO | Abeona Therapeutics Inc. | 305.49M | -1.65% | 1,013,050 | 14.54M |
| 263 | FENC | Fennec Pharmaceuticals Inc. | 302.21M | -0.80% | 144,236 | 51.00M |
| 264 | HUMA | Humacyte, Inc. | 297.51M | -3.60% | 7,975,015 | 2.02M |
| 265 | NMRA | Neumora Therapeutics, Inc. | 292.30M | -3.03% | 671,242 | - |
| 266 | DMAC | DiaMedica Therapeutics Inc. | 287.20M | -1.66% | 155,801 | - |
| 267 | NAUT | Nautilus Biotechnology, Inc. | 287.20M | -3.83% | 233,325 | - |
| 268 | SLN | Silence Therapeutics plc | 284.12M | 0.08% | 140,944 | 839.00K |
| 269 | RCKT | Rocket Pharmaceuticals, Inc. | 283.90M | -1.89% | 2,423,975 | - |
| 270 | IKT | Inhibikase Therapeutics, Inc. | 282.90M | -0.60% | 645,438 | 1.00 |
| 271 | BCYC | Bicycle Therapeutics plc | 281.34M | -3.36% | 237,603 | 63.50M |
| 272 | PALI | Palisade Bio, Inc. | 281.27M | -0.59% | 1,359,753 | - |
| 273 | INDP | Indaptus Therapeutics, Inc. | 277.44M | 20.99% | 1,507,147 | - |
| 274 | ARMP | Armata Pharmaceuticals, Inc. | 277.42M | -2.83% | 28,077 | 5.20M |
| 275 | NAGE | Niagen Bioscience, Inc. | 276.95M | -1.14% | 550,104 | 130.42M |
| 276 | NVCT | Nuvectis Pharma, Inc. | 273.48M | 5.20% | 100,123 | - |
| 277 | ELDN | Eledon Pharmaceuticals, Inc. | 267.47M | -2.54% | 754,197 | - |
| 278 | IVVD | Invivyd, Inc. | 265.41M | -9.00% | 5,436,755 | 55.87M |
| 279 | ELTX | Elicio Therapeutics, Inc. | 263.06M | 0.70% | 258,626 | - |
| 280 | ZNTL | Zentalis Pharmaceuticals, Inc. | 256.27M | 0.56% | 562,378 | 26.87M |
| 281 | IMRX | Immuneering Corporation | 253.61M | -2.73% | 1,113,327 | - |
| 282 | SRZN | Surrozen, Inc. | 252.76M | 1.86% | 53,398 | 7.49M |
| 283 | MGNX | MacroGenics, Inc. | 245.98M | -1.02% | 501,181 | 157.08M |
| 284 | OBIO | Orchestra BioMed Holdings, Inc. | 240.72M | -0.25% | 288,724 | 32.72M |
| 285 | SLGL | Sol-Gel Technologies Ltd. | 240.27M | -3.57% | 21,488 | 18.47M |
| 286 | IFRX | InflaRx N.V. | 238.61M | -2.41% | 955,351 | 33.82K |
| 287 | FULC | Fulcrum Therapeutics, Inc. | 233.88M | -0.28% | 2,459,792 | 80.00M |
| 288 | SABS | SAB Biotherapeutics, Inc. | 232.61M | -1.49% | 214,321 | 114.70K |
| 289 | CLLS | Cellectis S.A. | 228.33M | 6.35% | 109,276 | 75.11M |
| 290 | AVXL | Anavex Life Sciences Corp. | 227.97M | -3.15% | 921,696 | - |
| 291 | FHTX | Foghorn Therapeutics Inc. | 226.05M | 0.39% | 161,477 | 28.22M |
| 292 | CAMP | Camp4 Therapeutics Corporation | 225.36M | 8.23% | 181,389 | 3.93M |
| 293 | ADAG | Adagene Inc. | 219.36M | -2.35% | 105,233 | 7.67M |
| 294 | YDES | YD Bio Limited | 218.34M | 5.61% | 21,996 | 510.36K |
| 295 | RNAC | Cartesian Therapeutics, Inc. | 218.30M | 8.47% | 545,680 | 1.78M |
| 296 | QTTB | Q32 Bio Inc. | 218.23M | 8.24% | 644,965 | 53.74M |
| 297 | FATE | Fate Therapeutics, Inc. | 217.97M | -1.58% | 2,059,537 | 6.32M |
| 298 | NERV | Minerva Neurosciences, Inc. | 217.57M | -1.48% | 78,764 | - |
| 299 | TRDA | Entrada Therapeutics, Inc. | 215.12M | -6.28% | 269,065 | 5.74M |
| 300 | CDXS | Codexis, Inc. | 213.61M | -4.86% | 693,650 | 78.09M |
| 301 | TARA | Protara Therapeutics, Inc. | 212.45M | -4.79% | 815,209 | - |
| 302 | ACIU | AC Immune SA | 210.31M | -6.19% | 560,616 | 4.62M |
| 303 | CHRS | Coherus Oncology, Inc. | 209.78M | -4.23% | 657,514 | 46.88M |
| 304 | LENZ | LENZ Therapeutics, Inc. | 206.31M | -3.09% | 338,266 | 20.99M |
| 305 | CNTN | Canton Strategic Holdings, Inc. | 205.92M | 10.07% | 1,024,726 | - |
| 306 | KPTI | Karyopharm Therapeutics Inc. | 205.44M | 4.83% | 284,893 | 151.12M |
| 307 | UNCY | Unicycive Therapeutics, Inc. | 205.32M | 5.78% | 1,030,228 | - |
| 308 | VYGR | Voyager Therapeutics, Inc. | 200.60M | -3.21% | 395,772 | 36.49M |
| 309 | RNA | Atrium Therapeutics, Inc. | 199.62M | -0.77% | 136,611 | 36.68M |
| 310 | WHWK | Whitehawk Therapeutics, Inc. | 198.80M | -4.74% | 135,610 | 7.15M |
| 311 | KROS | Keros Therapeutics, Inc. | 196.53M | -1.39% | 190,365 | 33.18M |
| 312 | ALXO | ALX Oncology Holdings Inc. | 196.46M | -5.81% | 708,058 | - |
| 313 | ARCT | Arcturus Therapeutics Holdings Inc. | 195.83M | -3.77% | 316,114 | 54.71M |
| 314 | HELP | Cybin Inc. | 193.64M | -1.28% | 403,536 | - |
| 315 | CGEN | Compugen Ltd. | 185.39M | -2.97% | 352,744 | 72.66M |
| 316 | NGEN | NervGen Pharma Corp. | 183.73M | -4.42% | 617,079 | - |
| 317 | MDWD | MediWound Ltd. | 178.13M | -3.04% | 69,907 | 14.48M |
| 318 | CRBU | Caribou Biosciences, Inc. | 177.53M | -2.72% | 967,767 | 11.20M |
| 319 | NBP | NovaBridge Biosciences | 176.94M | -3.77% | 435,860 | - |
| 320 | NKTX | Nkarta, Inc. | 176.00M | 0.41% | 517,485 | - |
| 321 | TNXP | Tonix Pharmaceuticals Holding Corp. | 174.71M | -4.36% | 1,153,124 | 17.56M |
| 322 | OKUR | OnKure Therapeutics, Inc. | 169.26M | -1.18% | 186,784 | - |
| 323 | EQ | Equillium, Inc. | 168.81M | -1.11% | 388,116 | 4.39M |
| 324 | ALEC | Alector, Inc. | 168.76M | -6.75% | 429,021 | 18.42M |
| 325 | DTIL | Precision BioSciences, Inc. | 166.42M | -5.98% | 319,028 | 45.07M |
| 326 | IPHA | Innate Pharma S.A. | 166.30M | 0.56% | 5,922 | 10.57M |
| 327 | MIST | Milestone Pharmaceuticals Inc. | 165.98M | 0.83% | 905,231 | 1.78M |
| 328 | TTRX | Turn Therapeutics Inc. | 164.73M | 9.40% | 61,122 | - |
| 329 | ABOS | Acumen Pharmaceuticals, Inc. | 162.15M | 2.51% | 445,400 | - |
| 330 | ENLV | Enlivex Ltd. | 162.13M | -2.89% | 296,392 | - |
| 331 | IMUX | Immunic, Inc. | 159.51M | -4.49% | 190,257 | - |
| 332 | PLX | Protalix BioTherapeutics, Inc. | 158.73M | -0.51% | 360,834 | 76.38M |
| 333 | GALT | Galectin Therapeutics Inc. | 156.74M | -1.24% | 263,365 | - |
| 334 | KRRO | Korro Bio, Inc. | 152.74M | -3.20% | 91,744 | 3.84M |
| 335 | TNYA | Tenaya Therapeutics, Inc. | 151.53M | -1.65% | 2,063,674 | 225.00K |
| 336 | ORMP | Oramed Pharmaceuticals Inc. | 151.43M | 1.37% | 173,662 | 2.00M |
| 337 | ANTX | AN2 Therapeutics, Inc. | 151.18M | 7.42% | 188,510 | - |
| 338 | TLSA | Tiziana Life Sciences Ltd | 150.00M | -4.92% | 132,741 | - |
| 339 | PRQR | ProQR Therapeutics N.V. | 148.56M | -4.08% | 466,197 | 15.73M |
| 340 | SPRO | Spero Therapeutics, Inc. | 147.07M | -1.17% | 762,512 | 61.19M |
| 341 | MOLN | Molecular Partners AG | 143.86M | -4.12% | 4,515 | 856.30K |
| 342 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 142.66M | - | 267,838 | - |
| 343 | ADCT | ADC Therapeutics SA | 139.91M | - | 3,105,746 | 79.18M |
| 344 | NRXP | NRx Pharmaceuticals, Inc. | 136.10M | -2.84% | 600,333 | 2.29M |
| 345 | KZIA | Kazia Therapeutics Limited | 133.92M | 2.63% | 85,006 | 1.27M |
| 346 | CNTX | Context Therapeutics Inc. | 133.22M | -4.61% | 508,522 | - |
| 347 | HURA | TuHURA Biosciences, Inc. | 132.46M | 2.97% | 417,775 | - |
| 348 | CNTB | Connect Biopharma Holdings Limited | 131.59M | -1.42% | 183,835 | 233.00K |
| 349 | ACOG | Alpha Cognition Inc. | 130.43M | -0.33% | 36,221 | 10.83M |
| 350 | SPRB | Spruce Biosciences, Inc. | 129.71M | -3.88% | 34,039 | 697.00K |
| 351 | MENS | Jyong Biotech Ltd. | 127.68M | -4.97% | 210,132 | - |
| 352 | AGEN | Agenus Inc. | 127.52M | -1.29% | 758,711 | 123.87M |
| 353 | GNLX | Genelux Corporation | 127.23M | -3.86% | 174,062 | 8.00K |
| 354 | GUTS | Fractyl Health, Inc. | 116.10M | 10.19% | 1,127,084 | 3.00K |
| 355 | NTHI | NeOnc Technologies Holdings, Inc. | 115.19M | 2.94% | 42,275 | 39.99K |
| 356 | ALPS | Alps Group Inc | 113.24M | -3.48% | 3,355 | 3.74M |
| 357 | OTLK | Outlook Therapeutics, Inc. | 107.57M | 26.29% | 23,160,981 | 333.14K |
| 358 | ENGN | enGene Therapeutics Inc. | 107.18M | -4.19% | 976,690 | - |
| 359 | PLYX | Polaryx Therapeutics, Inc. | 107.00M | -0.88% | 48,329 | - |
| 360 | BDTX | Black Diamond Therapeutics, Inc. | 106.01M | -2.63% | 1,549,705 | 70.00M |
| 361 | PYXS | Pyxis Oncology, Inc. | 105.80M | -1.76% | 119,536 | 13.86M |
| 362 | COYA | Coya Therapeutics, Inc. | 103.68M | -1.34% | 116,527 | 7.94M |
| 363 | ALDX | Aldeyra Therapeutics, Inc. | 101.94M | -1.74% | 916,678 | - |
| 364 | CGTX | Cognition Therapeutics, Inc. | 101.86M | -0.87% | 489,157 | - |
| 365 | CRDF | Cardiff Oncology, Inc. | 101.19M | -3.27% | 1,197,723 | 525.00K |
| 366 | KLRS | Kalaris Therapeutics, Inc. | 98.98M | 2.33% | 47,848 | - |
| 367 | VRCA | Verrica Pharmaceuticals Inc. | 98.78M | -6.05% | 51,974 | 37.16M |
| 368 | VANI | Vivani Medical, Inc. | 97.45M | -0.88% | 56,063 | - |
| 369 | ONCY | Oncolytics Biotech Inc. | 95.50M | -1.22% | 2,070,804 | - |
| 370 | PEPG | PepGen Inc. | 95.45M | - | 478,030 | - |
| 371 | PTHS | Pelthos Therapeutics Inc. | 95.30M | 1.93% | 31,988 | 27.70M |
| 372 | SEER | Seer, Inc. | 92.92M | - | 78,673 | 15.17M |
| 373 | FBIO | Fortress Biotech, Inc. | 92.02M | -5.46% | 300,634 | 66.16M |
| 374 | CBUS | Cibus, Inc. | 91.54M | -2.44% | 277,646 | 3.64M |
| 375 | PMN | ProMIS Neurosciences, Inc. | 91.47M | 4.62% | 25,350 | - |
| 376 | CUE | Cue Biopharma, Inc. | 90.69M | -8.48% | 37,381 | 32.73M |
| 377 | ICCC | ImmuCell Corporation | 90.29M | 2.15% | 32,413 | 29.93M |
| 378 | INO | Inovio Pharmaceuticals, Inc. | 89.31M | -0.91% | 881,396 | 65.34K |
| 379 | ATRA | Atara Biotherapeutics, Inc. | 88.84M | 0.92% | 56,297 | 23.14M |
| 380 | PYPD | PolyPid Ltd. | 86.48M | -1.31% | 52,115 | - |
| 381 | RNTX | Rein Therapeutics Inc. | 85.63M | - | 248,683 | - |
| 382 | RLYB | Rallybio Corporation | 84.32M | 0.19% | 13,540 | 858.00K |
| 383 | NRXS | NeurAxis, Inc. | 84.21M | - | 61,810 | 4.28M |
| 384 | BMEA | Biomea Fusion, Inc. | 83.14M | 1.32% | 732,446 | - |
| 385 | LIXT | Lixte Biotechnology Holdings, Inc. | 80.05M | 0.29% | 189,900 | - |
| 386 | HYFT | MindWalk Holdings Corp. | 79.96M | -3.01% | 1,006,362 | 20.70M |
| 387 | CSBR | Champions Oncology, Inc. | 79.43M | -1.21% | 1,776 | 57.95M |
| 388 | LONA | LeonaBio, Inc. | 79.19M | -0.35% | 12,987 | - |
| 389 | ANIX | Anixa Biosciences, Inc. | 78.79M | -2.08% | 113,049 | - |
| 390 | RANI | Rani Therapeutics Holdings, Inc. | 78.15M | -3.48% | 572,501 | 3.17M |
| 391 | OKYO | OKYO Pharma Limited | 77.67M | -3.89% | 76,748 | - |
| 392 | HRTX | Heron Therapeutics, Inc. | 77.30M | 0.86% | 4,127,737 | 150.71M |
| 393 | MAIA | MAIA Biotechnology, Inc. | 77.22M | -2.31% | 973,638 | - |
| 394 | ACET | Adicet Bio, Inc. | 76.76M | - | 34,919 | - |
| 395 | AARD | Aardvark Therapeutics, Inc. | 75.92M | -2.79% | 104,747 | - |
| 396 | OSTX | OS Therapies Incorporated | 75.27M | -2.87% | 302,326 | - |
| 397 | ANVS | Annovis Bio, Inc. | 73.17M | -2.82% | 1,119,969 | - |
| 398 | PLRX | Pliant Therapeutics, Inc. | 71.83M | -2.52% | 345,558 | - |
| 399 | XBIT | XBiotech Inc. | 71.65M | -0.84% | 14,913 | - |
| 400 | ATHE | Alterity Therapeutics Limited | 71.19M | -3.26% | 23,883 | 4.43M |
| 401 | GANX | Gain Therapeutics, Inc. | 69.95M | -0.61% | 362,500 | - |
| 402 | BYSI | BeyondSpring Inc. | 67.85M | -4.07% | 8,702 | 1.88M |
| 403 | EXOZ | eXoZymes, Inc. | 66.05M | -0.13% | 11,021 | -700.00 |
| 404 | CING | Cingulate Inc. | 64.92M | 5.16% | 315,852 | - |
| 405 | FLNA | Filana Therapeutics, Inc. | 63.77M | -7.04% | 235,987 | - |
| 406 | MCRB | Seres Therapeutics, Inc. | 62.85M | 3.00% | 72,610 | 1.15M |
| 407 | MNOV | MediciNova, Inc. | 62.51M | - | 21,890 | 596.64K |
| 408 | IMA | ImageneBio, Inc. | 62.26M | -0.54% | 10,398 | 800.00K |
| 409 | IBIO | iBio, Inc. | 61.44M | - | 507,113 | 300.00K |
| 410 | IBO | Impact BioMedical Inc. | 61.35M | -1.32% | 120,738 | 39.00K |
| 411 | INKT | MiNK Therapeutics, Inc. | 60.73M | 3.13% | 27,877 | - |
| 412 | TCRX | TScan Therapeutics, Inc. | 60.02M | -4.87% | 288,834 | 9.14M |
| 413 | PDSB | PDS Biotechnology Corporation | 59.16M | 2.91% | 998,544 | - |
| 414 | ACRV | Acrivon Therapeutics, Inc. | 59.07M | -2.82% | 216,115 | - |
| 415 | ENTX | Entera Bio Ltd. | 58.09M | -3.28% | 16,583 | 42.00K |
| 416 | PMVP | PMV Pharmaceuticals, Inc. | 56.53M | 0.95% | 150,574 | - |
| 417 | TIL | Instil Bio, Inc. | 54.19M | -0.37% | 8,117 | - |
| 418 | RADX | Radiopharm Theranostics Limited | 49.77M | 1.41% | 7,631 | 10.86M |
| 419 | DWTX | Dogwood Therapeutics, Inc. | 49.77M | 2.76% | 73,121 | - |
| 420 | LTRN | Lantern Pharma Inc. | 49.50M | 1.84% | 152,287 | - |
| 421 | MREO | Mereo BioPharma Group plc | 48.63M | -0.33% | 2,396,712 | 500.00K |
| 422 | XLO | Xilio Therapeutics, Inc. | 47.80M | 1.14% | 10,632 | 53.48M |
| 423 | ESLA | Estrella Immunopharma, Inc. | 47.77M | -3.48% | 30,339 | - |
| 424 | IMMP | Immutep Limited | 47.60M | -3.58% | 363,945 | 5.28M |
| 425 | VERU | Veru Inc. | 47.35M | -4.84% | 876,406 | 16.89M |
| 426 | ACTU | Actuate Therapeutics, Inc. | 46.66M | -2.99% | 140,758 | - |
| 427 | MGX | Metagenomi Therapeutics, Inc. | 46.31M | - | 75,052 | 22.33M |
| 428 | EDSA | Edesa Biotech, Inc. | 46.29M | 5.47% | 149,917 | - |
| 429 | ATYR | aTyr Pharma, Inc. | 45.93M | 2.81% | 969,333 | 190.00K |
| 430 | KALA | KALA BIO, Inc. | 44.43M | 1.70% | 74,224 | - |
| 431 | ELOX | Eloxx Pharmaceuticals, Inc. | 44.40M | -0.09% | 119,188 | - |
| 432 | TVGN | Tevogen Bio Holdings Inc. | 44.35M | -1.49% | 44,595 | - |
| 433 | TELO | Telomir Pharmaceuticals, Inc. | 42.63M | 2.48% | 76,482 | - |
| 434 | NTRB | Nutriband Inc. | 41.45M | -3.40% | 17,752 | 2.04M |
| 435 | GNTA | Genenta Science S.p.A. | 38.93M | 3.12% | 516,121 | - |
| 436 | GRDX | GridAI Technologies Corp. | 38.52M | -9.11% | 69,013 | - |
| 437 | RNXT | RenovoRx, Inc. | 38.37M | -1.08% | 226,462 | 1.49M |
| 438 | ATOS | Atossa Therapeutics, Inc. | 37.89M | -0.23% | 29,872 | - |
| 439 | PSTV | Plus Therapeutics, Inc. | 37.10M | -2.00% | 126,285 | 5.18M |
| 440 | GOSS | Gossamer Bio, Inc. | 36.61M | -2.50% | 34,015,765 | 55.54M |
| 441 | HYPD | Hyperion DeFi, Inc. | 35.80M | -2.70% | 261,170 | 1.04M |
| 442 | GRCE | Grace Therapeutics, Inc. | 35.75M | -0.86% | 133,583 | - |
| 443 | ATNM | Actinium Pharmaceuticals, Inc. | 32.94M | 3.96% | 151,162 | 90.00K |
| 444 | LSTA | Lisata Therapeutics, Inc. | 32.61M | 4.34% | 866,953 | 170.00K |
| 445 | ABVC | ABVC BioPharma, Inc. | 32.60M | -2.27% | 53,776 | 797.92K |
| 446 | INMB | INmune Bio Inc. | 32.17M | -0.82% | 207,035 | 50.00K |
| 447 | ALGS | Aligos Therapeutics, Inc. | 31.93M | 0.39% | 32,462 | 4.71M |
| 448 | EVAX | Evaxion A/S | 31.61M | 4.41% | 24,995 | 7.53M |
| 449 | BOLD | Boundless Bio, Inc. | 30.94M | -1.43% | 52,555 | - |
| 450 | NNVC | NanoViricides, Inc. | 30.53M | -4.29% | 329,661 | - |
| 451 | APLM | Apollomics, Inc. | 30.28M | -3.57% | 3,685 | 8.84M |
| 452 | DARE | Daré Bioscience, Inc. | 29.96M | 4.17% | 157,849 | 1.16M |
| 453 | SNTI | Senti Biosciences Holdings, Inc. | 29.90M | 6.01% | 206,533 | 38.00K |
| 454 | BRNS | Barinthus Biotherapeutics plc | 28.33M | -4.20% | 23,784 | 14.97M |
| 455 | IGC | IGC Pharma, Inc. | 27.76M | -1.40% | 242,277 | 1.11M |
| 456 | SKYE | Skye Bioscience, Inc. | 27.40M | 3.88% | 138,157 | - |
| 457 | KYNB | Kyntra Bio, Inc. | 27.08M | 4.48% | 11,267 | 7.44M |
| 458 | DYAI | Dyadic International, Inc. | 26.60M | 8.07% | 166,684 | 3.81M |
| 459 | SER | Serina Therapeutics, Inc. | 25.92M | -1.69% | 55,087 | 130.00K |
| 460 | NRSN | NeuroSense Therapeutics Ltd. | 25.85M | -3.78% | 133,495 | - |
| 461 | TVRD | Tvardi Therapeutics, Inc. | 25.42M | -2.52% | 53,584 | - |
| 462 | BCTX | BriaCell Therapeutics Corp. | 25.17M | -6.19% | 261,989 | - |
| 463 | LITS | Lite Strategy, Inc. | 25.12M | -2.37% | 206,901 | - |
| 464 | PTN | Palatin Technologies, Inc. | 24.91M | -3.94% | 6,840 | 12.88M |
| 465 | QNTM | Quantum BioPharma Ltd. | 24.53M | 1.03% | 187,493 | - |
| 466 | PLUR | Pluri Inc. | 24.38M | -5.04% | 6,563 | 1.08M |
| 467 | LGVN | Longeveron Inc. | 23.99M | -0.32% | 133,630 | 1.22M |
| 468 | NEUP | Neuphoria Therapeutics Inc. | 23.89M | -5.15% | 66,997 | -13.27K |
| 469 | MRKR | Marker Therapeutics, Inc. | 23.84M | 1.42% | 27,540 | 3.55M |
| 470 | ALLR | Allarity Therapeutics, Inc. | 23.04M | -7.45% | 271,345 | 345.00K |
| 471 | CELU | Celularity Inc. | 22.39M | 12.36% | 70,273 | 26.55M |
| 472 | VYNE | VYNE Therapeutics Inc. | 21.95M | -1.79% | 21,721 | 454.00K |
| 473 | VTGN | Vistagen Therapeutics, Inc. | 21.20M | -0.50% | 489,987 | 789.00K |
| 474 | CRVO | CervoMed Inc. | 20.83M | -22.15% | 1,087,102 | 2.09M |
| 475 | PLRZ | Polyrizon Ltd. | 20.70M | -3.41% | 37,275 | - |
| 476 | KTTA | Pasithea Therapeutics Corp. | 19.39M | 0.03% | 180,470 | - |
| 477 | TRAW | Traws Pharma, Inc. | 18.94M | -4.58% | 443,499 | 2.73M |
| 478 | AEON | AEON Biopharma, Inc. | 18.68M | -0.92% | 59,435 | - |
| 479 | TPST | Tempest Therapeutics, Inc. | 18.22M | - | 27,449 | - |
| 480 | CLRB | Cellectar Biosciences, Inc. | 18.06M | -4.24% | 111,869 | - |
| 481 | HOWL | Werewolf Therapeutics, Inc. | 17.74M | -2.54% | 171,640 | 1.14M |
| 482 | XCUR | Exicure, Inc. | 17.59M | -3.16% | 17,901 | 500.00K |
| 483 | CRIS | Curis, Inc. | 17.26M | -2.97% | 154,278 | 7.06M |
| 484 | CVM | CEL-SCI Corporation | 17.10M | -9.23% | 357,359 | - |
| 485 | NCEL | NewcelX Ltd. | 17.07M | - | 25,009 | - |
| 486 | AKTX | Akari Therapeutics, Plc | 16.75M | -2.47% | 39,029 | - |
| 487 | PASG | Passage Bio, Inc. | 16.46M | -7.90% | 71,959 | - |
| 488 | LEXX | Lexaria Bioscience Corp. | 16.26M | -1.80% | 117,152 | 368.00K |
| 489 | LPCN | Lipocine Inc. | 15.89M | -3.41% | 110,630 | 2.00M |
| 490 | SNSE | Sensei Biotherapeutics, Inc. | 15.31M | -9.66% | 52,031 | - |
| 491 | HIND | Vyome Holdings, Inc. | 15.27M | 3.08% | 13,303 | 152.72K |
| 492 | CTXR | Citius Pharmaceuticals, Inc. | 15.18M | -0.54% | 285,915 | 5.61M |
| 493 | MLEC | Moolec Science SA | 15.08M | 1.12% | 23,360 | 7.83M |
| 494 | GTBP | GT Biopharma, Inc. | 14.97M | -0.67% | 549,709 | - |
| 495 | QNCX | Quince Therapeutics, Inc. | 14.83M | -6.19% | 325,242 | - |
| 496 | CALC | CalciMedica, Inc. | 14.67M | 2.36% | 193,528 | - |
| 497 | OSRH | OSR Holdings, Inc. | 14.66M | 3.75% | 605,192 | 2.63M |
| 498 | COCP | Cocrystal Pharma, Inc. | 13.79M | -1.96% | 50,041 | 225.00K |
| 499 | INAB | IN8bio, Inc. | 13.79M | -3.45% | 37,676 | - |
| 500 | MBRX | Moleculin Biotech, Inc. | 13.34M | 3.73% | 100,577 | - |